Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2008 2
2011 1
2013 2
2014 1
2016 2
2019 1
2020 5
2021 9
2022 8
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis R, Harrison TW, Chanez P, Menzella F, Philteos G, Cosio BG, Lugogo NL, de Luiz G, Burden A, Adlington T, Keeling N, Kwiatek J, Garcia Gil E; ANDHI Study Investigators. Louis R, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1759-1770.e7. doi: 10.1016/j.jaip.2023.03.009. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36948488 Free article.
Genomics of Treatable Traits in Asthma.
Espuela-Ortiz A, Martin-Gonzalez E, Poza-Guedes P, González-Pérez R, Herrera-Luis E. Espuela-Ortiz A, et al. Among authors: gonzalez perez r. Genes (Basel). 2023 Sep 20;14(9):1824. doi: 10.3390/genes14091824. Genes (Basel). 2023. PMID: 37761964 Free PMC article. Review.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Precision Medicine in Mite Allergic Rhinitis.
González-Pérez R, El-Qutob D, Letrán A, Matheu V. González-Pérez R, et al. Front Allergy. 2021 Sep 27;2:724727. doi: 10.3389/falgy.2021.724727. eCollection 2021. Front Allergy. 2021. PMID: 35387006 Free PMC article. Review.
Human genetics influences microbiome composition involved in asthma exacerbations despite inhaled corticosteroid treatment.
Perez-Garcia J, Espuela-Ortiz A, Hernández-Pérez JM, González-Pérez R, Poza-Guedes P, Martin-Gonzalez E, Eng C, Sardón-Prado O, Mederos-Luis E, Corcuera-Elosegui P, Sánchez-Machín I, Korta-Murua J, Villar J, Burchard EG, Lorenzo-Diaz F, Pino-Yanes M. Perez-Garcia J, et al. Among authors: gonzalez perez r. J Allergy Clin Immunol. 2023 Sep;152(3):799-806.e6. doi: 10.1016/j.jaci.2023.05.021. Epub 2023 Jun 8. J Allergy Clin Immunol. 2023. PMID: 37301411 Free PMC article.
Multi-ancestry genome-wide association study of asthma exacerbations.
Herrera-Luis E, Ortega VE, Ampleford EJ, Sio YY, Granell R, de Roos E, Terzikhan N, Vergara EE, Hernandez-Pacheco N, Perez-Garcia J, Martin-Gonzalez E, Lorenzo-Diaz F, Hashimoto S, Brinkman P; U-BIOPRED Study Group; Jorgensen AL, Yan Q, Forno E, Vijverberg SJ, Lethem R, Espuela-Ortiz A, Gorenjak M, Eng C, González-Pérez R, Hernández-Pérez JM, Poza-Guedes P, Sardón O, Corcuera P, Hawkins GA, Marsico A, Bahmer T, Rabe KF, Hansen G, Kopp MV, Rios R, Cruz MJ, González-Barcala FJ, Olaguibel JM, Plaza V, Quirce S, Canino G, Cloutier M, Del Pozo V, Rodriguez-Santana JR, Korta-Murua J, Villar J, Potočnik U, Figueiredo C, Kabesch M, Mukhopadhyay S, Pirmohamed M, Hawcutt DB, Melén E, Palmer CN, Turner S, Maitland-van der Zee AH, von Mutius E, Celedón JC, Brusselle G, Chew FT, Bleecker E, Meyers D, Burchard EG, Pino-Yanes M. Herrera-Luis E, et al. Among authors: gonzalez perez r. Pediatr Allergy Immunol. 2022 Jun;33(6):e13802. doi: 10.1111/pai.13802. Pediatr Allergy Immunol. 2022. PMID: 35754128 Free PMC article.
Comment on Platts-Mills et al.
González-Pérez R, Poza-Guedes P, Pineda F. González-Pérez R, et al. Pediatr Allergy Immunol. 2023 Jul;34(7):e13986. doi: 10.1111/pai.13986. Pediatr Allergy Immunol. 2023. PMID: 37492915 No abstract available.
Molecular Mapping of Allergen Exposome among Different Atopic Phenotypes.
González-Pérez R, Poza-Guedes P, Pineda F, Galán T, Mederos-Luis E, Abel-Fernández E, Martínez MJ, Sánchez-Machín I. González-Pérez R, et al. Int J Mol Sci. 2023 Jun 21;24(13):10467. doi: 10.3390/ijms241310467. Int J Mol Sci. 2023. PMID: 37445644 Free PMC article.
The upper-airway microbiome as a biomarker of asthma exacerbations despite inhaled corticosteroid treatment.
Perez-Garcia J, González-Carracedo M, Espuela-Ortiz A, Hernández-Pérez JM, González-Pérez R, Sardón-Prado O, Martin-Gonzalez E, Mederos-Luis E, Poza-Guedes P, Corcuera-Elosegui P, Callero A, Sánchez-Machín I, Korta-Murua J, Pérez-Pérez JA, Villar J, Pino-Yanes M, Lorenzo-Diaz F. Perez-Garcia J, et al. Among authors: gonzalez perez r. J Allergy Clin Immunol. 2023 Mar;151(3):706-715. doi: 10.1016/j.jaci.2022.09.041. Epub 2022 Nov 4. J Allergy Clin Immunol. 2023. PMID: 36343772 Free article.
40 results